Efficacy of charcoal cathartic versus ipecac in reducing serum acetaminophen in a simulated overdose

Annals of Emergency Medicine
R M McNamaraS Davidheiser

Abstract

The traditional role of gastric emptying as the initial step in the management of the poisoned patient has recently been questioned; immediate activated charcoal administration has been recommended by some. In the setting of acetaminophen overdose, ipecac-induced emesis may interfere with subsequent oral antidotal therapy. Therefore, we conducted a study to compare the efficacy of initial therapy with ipecac with therapy with activated charcoal-cathartic in a simulated acetaminophen overdosage. Ten healthy volunteers participated in a randomized, crossover trial. Subjects ingested 3.0 g acetaminophen, followed by either no intervention, 30 mL syrup of ipecac, or 50 g activated charcoal-sorbitol solution at one hour. Serial acetaminophen levels were determined at intervals over eight hours. Both interventions significantly reduced the area under the curve compared with control (P less than .05). When comparing ipecac with activated charcoal-cathartic, no significant difference was noted among these groups.

References

Apr 1, 1977·Journal of Pharmaceutical Sciences·C A BainbridgeW D Walking
Apr 20, 1977·European Journal of Clinical Pharmacology·M D RawlinsA R Hijab
Jun 1, 1985·Annals of Emergency Medicine·K KuligB H Rumack
Jan 1, 1987·The Journal of Emergency Medicine·B G KatonaR J Cluxton
May 1, 1986·Archives of Internal Medicine·G D ParkG F Johnson
Sep 1, 1987·The American Journal of Emergency Medicine·T L LitovitzB Schmitz
Nov 1, 1987·The American Journal of Emergency Medicine·B R EkinsR D Jenkins
Jan 30, 1986·The New England Journal of Medicine·H H Harsch
Jan 1, 1986·Annals of Emergency Medicine·E P Krenzelok
Jun 1, 1985·Annals of Emergency Medicine·F P RenziE F Harrison
Aug 1, 1972·The Journal of Pharmacy and Pharmacology·I J McGilveray, G L Mattok
Feb 1, 1967·British Journal of Pharmacology and Chemotherapy·A J CummingsB K Martin
Jan 1, 1981·Annals of Emergency Medicine·A R Soslow
Oct 1, 1981·Annals of Emergency Medicine·D TandbergD Fishbein
Jan 1, 1983·European Journal of Clinical Pharmacology·P J NeuvonenO Tokola
Dec 1, 1984·Annals of Emergency Medicine·W Klein-SchwartzD Saggar
Jan 1, 1984·The Journal of Emergency Medicine·K Kulig
Aug 1, 1983·Journal of Pharmaceutical Sciences·B AmeerL Shargel
Apr 1, 1982·Journal of Toxicology. Clinical Toxicology·E G ComstockT P Faulkner
Oct 1, 1981·Annals of Emergency Medicine·M M PollackA I Fields
Oct 1, 1981·Annals of Emergency Medicine·B H Rumack, P Rosen
Feb 23, 1981·Archives of Internal Medicine·B H RumackI A Amara
Feb 23, 1981·Archives of Internal Medicine·L F Prescott

Citations

Jun 1, 1993·Journal of Clinical Pharmacology·S PhillipsJ Brent
Oct 1, 1993·Pharmacology & Therapeutics·S H Thomas
Aug 7, 1995·Ugeskrift for laeger·H Ring-Larsen
Apr 14, 2000·Current Opinion in Pediatrics·L S Quang, Alan D Woolf
Jan 9, 1993·BMJ : British Medical Journal·J A Vale, A T Proudfoot
Oct 14, 2011·International Journal of Emergency Medicine·Timothy E AlbertsonAndrew L Chan
Dec 4, 2015·Expert Review of Gastroenterology & Hepatology·Jonathan G Stine, James H Lewis
Jan 1, 1997·Journal of Toxicology. Clinical Toxicology·A SaincherM Tenenbein
Jan 1, 1994·Journal of Toxicology. Clinical Toxicology·C A GentryK A Rodvold
Apr 13, 2005·Clinical Toxicology : the Official Journal of the American Academy of Clinical Toxicology and European Association of Poisons Centres and Clinical Toxicologists·Peter A ChykaEuropean Association of Poisons Centres and Clinical Toxicologists
Mar 1, 2005·Clinical Toxicology : the Official Journal of the American Academy of Clinical Toxicology and European Association of Poisons Centres and Clinical Toxicologists·Anthony S ManoguerraGuidelines for the Management of Poisoning Consensus Panel
Feb 15, 2013·Clinical Toxicology : the Official Journal of the American Academy of Clinical Toxicology and European Association of Poisons Centres and Clinical Toxicologists·J HöjerEuropean Association of Poison Centres and Clinical Toxicologists
Jun 25, 2004·Journal of Toxicology. Clinical Toxicology
Jan 20, 2006·Pediatric Annals·J Dave Barry
Jun 1, 2000·Annals of Emergency Medicine·B A Wolsey, P E McKinney
Feb 1, 1992·Annals of Emergency Medicine·D ClineD Seaberg
Jan 12, 2000·Pediatric Clinics of North America·M Tenenbein
Jun 1, 1991·Annals of Emergency Medicine·A E Kornberg, J Dolgin
Jun 26, 2015·Journal of Medical Toxicology : Official Journal of the American College of Medical Toxicology·Matthew ZuckermanKavita M Babu
Apr 21, 2006·The Cochrane Database of Systematic Reviews·J BrokC Gluud
Jan 1, 1993·Postgraduate Medical Journal·J A Vale
Feb 25, 2006·Clinical Toxicology : the Official Journal of the American Academy of Clinical Toxicology and European Association of Poisons Centres and Clinical Toxicologists·Richard C DartAmerican Association of Poison Control Centers
Mar 2, 1992·The Medical Journal of Australia·D JawaryJ J McNeil

Related Concepts

Algotropyl
Teens
Bowel Preparation Solutions
Ultracarbon
Drug Evaluation
Gastric Emptying
Ipecac
Randomization

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Alzheimer's Disease: MS4A

Variants within the membrane-spanning 4-domains subfamily A (MS4A) gene cluster have recently been implicated in Alzheimer's disease in genome-wide association studies. Here is the latest research on Alzheimer's disease and MS4A.

Pediculosis pubis

Pediculosis pubis is a disease caused by a parasitic insect known as Pthirus pubis, which infests human pubic hair, as well as other areas with hair including eye lashes. Here is the latest research.

Rh Isoimmunization

Rh isoimmunization is a potentially preventable condition that occasionally is associated with significant perinatal morbidity or mortality. Discover the latest research on Rh Isoimmunization here.

Genetic Screens in iPSC-derived Brain Cells

Genetic screening is a critical tool that can be employed to define and understand gene function and interaction. This feed focuses on genetic screens conducted using induced pluripotent stem cell (iPSC)-derived brain cells. It also follows CRISPR-Cas9 approaches to generating genetic mutants as a means of understanding the effect of genetics on phenotype.

Enzyme Evolution

This feed focuses on molecular models of enzyme evolution and new approaches (such as adaptive laboratory evolution) to metabolic engineering of microorganisms. Here is the latest research.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Pharmacology of Proteinopathies

This feed focuses on the pharmacology of proteinopathies - diseases in which proteins abnormally aggregate (i.e. Alzheimer’s, Parkinson’s, etc.). Discover the latest research in this field with this feed.

Alignment-free Sequence Analysis Tools

Alignment-free sequence analyses have been applied to problems ranging from whole-genome phylogeny to the classification of protein families, identification of horizontally transferred genes, and detection of recombined sequences. Here is the latest research.